UiPath
Security and trust center evidence
Summary
UiPath has 3 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.
Reviewer brief
As of 17 Sep 2026, UiPath is listed in the FedRAMP registry as FedRAMP Authorized, with authorization issued 20 Mar 2024 and audited by Schellman Compliance, LLC. As of 17 Sep 2026, UiPath is listed in the CSA STAR registry at Level 1 self-assessment (CAIQ), issued 26 Feb 2026. As of 17 Sep 2026, UiPath is listed in the EU-US Data Privacy Framework registry as active, covering SW-US, EU-US, and UK Extension Certifications, issued 09 Jan 2020 and set to expire 06 Aug 2027. No public evidence found for SOC 2 as of 17 Sep 2026. No public evidence found for HIPAA as of 17 Sep 2026.
- FedRAMP: listed in FedRAMP registry as Authorized, issued 20 Mar 2024, audited by Schellman Compliance, LLC (as of 17 Sep 2026)
- CSA STAR: listed in CSA STAR registry, Level 1 self-assessment (CAIQ), issued 26 Feb 2026 (as of 17 Sep 2026)
- EU-US Data Privacy Framework: listed as active (SW-US, EU-US, UK Extension), issued 09 Jan 2020, expires 06 Aug 2027 (as of 17 Sep 2026)
Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.
Among devops and observability vendors
3verified rows
Category median 1, across 90 indexed devops and observability vendors. UiPath has more verified rows than 100 percent of them.
ai automationprocess automationrpaworkflow automation
Compare with similar vendors
Pick your own comparisonCompliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this. Check the vendor trust centre.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the DevOps and observability category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.
